These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 29595531)
21. Oxygenator impact on meropenem/vaborbactam in extracorporeal membrane oxygenation circuits. Cies JJ; Nikolos P; Moore WS; Giliam N; Low T; Marino D; Deacon J; Enache A; Chopra A Perfusion; 2022 Oct; 37(7):729-737. PubMed ID: 34034594 [TBL] [Abstract][Full Text] [Related]
22. Cefiderocol is Not Sequestered in an Ex Vivo Extracorporeal Membrane Oxygenation (ECMO) Circuit. Berry AV; Conelius A; Gluck JA; Nicolau DP; Kuti JL Eur J Drug Metab Pharmacokinet; 2023 Jul; 48(4):437-441. PubMed ID: 37351777 [TBL] [Abstract][Full Text] [Related]
23. In vitro clearance of dexmedetomidine in extracorporeal membrane oxygenation. Wagner D; Pasko D; Phillips K; Waldvogel J; Annich G Perfusion; 2013 Jan; 28(1):40-6. PubMed ID: 22891035 [TBL] [Abstract][Full Text] [Related]
24. Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment. Mehta NM; Halwick DR; Dodson BL; Thompson JE; Arnold JH Intensive Care Med; 2007 Jun; 33(6):1018-24. PubMed ID: 17404709 [TBL] [Abstract][Full Text] [Related]
25. In vitro effects of an extracorporeal membrane oxygenation circuit on the sequestration of ϵ-aminocaproic acid. Wagner D; Caraballo M; Waldvogel J; Peterson Y; Sun D Perfusion; 2017 Apr; 32(3):226-229. PubMed ID: 27815558 [TBL] [Abstract][Full Text] [Related]
26. Effects of Zhang Y; Hu H; Zhang Q; Ou Q; Zhou H; Sha T; Zeng Z; Wu J; Lu J; Chen Z Front Med (Lausanne); 2021; 8():748769. PubMed ID: 34926498 [No Abstract] [Full Text] [Related]
27. In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation. Mulla H; Lawson G; von Anrep C; Burke MD; Upton DU; Firmin RK; Killer H Perfusion; 2000 Jan; 15(1):21-6. PubMed ID: 10676864 [TBL] [Abstract][Full Text] [Related]
28. Investigation of Key Circuit Constituents Affecting Drug Sequestration During Extracorporeal Membrane Oxygenation Treatment. Park J; Shin DA; Lee S; Cho YJ; Jheon S; Lee JC; Kim HC ASAIO J; 2017; 63(3):293-298. PubMed ID: 27922880 [TBL] [Abstract][Full Text] [Related]
30. Feasibility of sedation and analgesia interruption following cannulation in neonates on extracorporeal membrane oxygenation. Wildschut ED; Hanekamp MN; Vet NJ; Houmes RJ; Ahsman MJ; Mathot RA; de Wildt SN; Tibboel D Intensive Care Med; 2010 Sep; 36(9):1587-91. PubMed ID: 20508914 [TBL] [Abstract][Full Text] [Related]
31. Impact of Extracorporeal Membrane Oxygenation Circuitry on Remdesivir. Cies JJ; Moore WS; Deacon J; Enache A; Chopra A J Pediatr Pharmacol Ther; 2024 Jun; 29(3):248-254. PubMed ID: 38863849 [TBL] [Abstract][Full Text] [Related]
32. In vitro clearance of intravenous acetaminophen in extracorporeal membrane oxygenation. Gillogly A; Kilbourn C; Waldvogel J; Martin J; Annich G; Wagner D Perfusion; 2013 Mar; 28(2):141-5. PubMed ID: 23201817 [TBL] [Abstract][Full Text] [Related]
33. Oxygenator impact on peramivir in extra-corporeal membrane oxygenation circuits. Cies JJ; Moore WS; Marino D; Deacon J; Enache A; Chopra A Perfusion; 2023 Apr; 38(3):501-506. PubMed ID: 35225084 [TBL] [Abstract][Full Text] [Related]
34. Extracorporeal membrane oxygenation and V/Q ratios: an ex vivo analysis of CO Zakhary B; Sheldrake J; Pellegrino V Perfusion; 2020 May; 35(1_suppl):29-33. PubMed ID: 32397880 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of Altered Drug Pharmacokinetics in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation. Ha MA; Sieg AC Pharmacotherapy; 2017 Feb; 37(2):221-235. PubMed ID: 27931091 [TBL] [Abstract][Full Text] [Related]